Filing Flows › Coherus Oncology (CHRS) › Other revenue revenue
Coherus Oncology (CHRS) Other revenue revenue by quarter
Coherus Oncology's Other revenue revenue was $694K in Q2 2026 (second quarter 2026), +37% from Q1 2026. Over the last 6 quarters it ranged from $251K (Q1 2025) to $694K (Q2 2026).
| Quarter | Other revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $694K | +37% | +135% |
| Q1 2026 | $507K | +31% | +102% |
| Q4 2025 | $388K | -3% | — |
| Q3 2025 | $402K | +36% | — |
| Q2 2025 | $295K | +18% | — |
| Q1 2025 | $251K | — | — |
Q2 2026 at a glance
Coherus Oncology, Q2 2026: revenue $14.3M (+40% year over year), operating margin -226.0%, net loss $20.6M, operating cash flow −$62.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Coherus Oncology's Other revenue revenue?
Coherus Oncology's Other revenue revenue was $694K in Q2 2026 (second quarter 2026), +37% from Q1 2026.
How has Coherus Oncology's Other revenue revenue changed?
Over the last 6 quarters it ranged from $251K (Q1 2025) to $694K (Q2 2026).